Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GSK and Vir announce EMA review of VIR-7831 for early treatment of Covid-19
GlaxoSmithKline and Vir Biotechnology have announced the European Medicines Agency (EMA) review of VIR-7831 (GSK4182136) for the early treatment of Covid-19.
Immunology
-
16 Apr 2021
-
23 Mar 2021
Dyadic and Medytox to co-develop Covid-19 variant fighting vaccines
US-based global biotechnology company Dyadic International has announced the expansion of its partnership with South Korea-based global research biopharmaceutical company Medytox to co-develop C1 manufactured Covid-19 vaccines.
-
19 Mar 2021
Boston Pharmaceuticals signs three-year agreement with GSK
The US-based clinical stage biopharmaceutical company Boston Pharmaceuticals has announced the signing of a unique three-year out-license and option agreement with the UK-based GlaxoSmithKline (GSK).
-
02 Feb 2021
Lilly to provide antibody therapies at Indiana hospitals for treating COVID-19
Eli Lilly and Company (Lilly) has joined hands with local health systems in the US state of Indiana to provide antibody therapies through dedicated infusion centre locations that will offer treatments for patients with COVID-19.